evaluation
safety
amantadine
hc
role
respiratory
viral
infections
children
cystic
fibrosis
amantadine
hc
antiviral
drug
clinically
effective
strains
influenza
virus
evaluated
double
blind
trial
children
cystic
fibrosis
initial
appearance
influenza
england
virus
new
england
area
infection
variant
strain
influenza
virus
reach
epidemic
proportions
study
effectiveness
amantadine
study
population
could
fully
assessed
however
potential
symptomatic
biochemical
toxicity
amantadine
carefully
monitored
pediatric
population
serologic
screening
complement
fixation
tests
indicated
respiratory
viruses
may
important
pathogens
exacerbations
respiratory
disease
patients
cystic
fibrosis
